Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Jullien

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
The Journal of Antimicrobial Chemotherapy|April 25, 2009
Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustmentMarion Bouillon-Pichault, Vincent Jullien, Elie Azria, et al.
British Journal of Haematology|March 23, 2021
Deficient mitophagy pathways in sickle cell diseaseSuella Martino, Jean-Benoit Arlet, Marie-Hélène Odièvre, et al.
Pediatric Research|July 2, 2020
Pharmacokinetic study (phase I-II) of a new dobutamine formulation in preterm infants immediately after birthAdelina Pellicer, Ramón Fernández, Vincent Jullien, et al.
Infection|April 4, 2015
Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infectionsEmmanuel Curis, Vincent Pestre, Vincent Jullien, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 yearsVincent Jullien, Saïk Urien, Déborah Hirt, et al.
European Journal of Dermatology : EJD|January 22, 2014
Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combinationOlivier Join-Lambert, Florence Ribadeau-Dumas, Vincent Jullien, et al.
Malaria Journal|September 7, 2016
Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in LiberiaSabina Dahlström Otienoburu, Oumou Maïga-Ascofaré, Birgit Schramm, et al.
Antiviral Therapy|November 18, 2009
A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patientsMarion Bouillon-Pichault, Vincent Jullien, Christophe Piketty, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 26, 2021
Development of a dosing-adjustment tool for fluoroquinolones in osteoarticular infections: The Fluo-pop studyFlorian Lemaitre, Fabien Fily, Jean-Baptiste Foulquier, et al.
The Pediatric Infectious Disease Journal|March 6, 2015
The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, UgandaImke H Bartelink, Rada M Savic, Grant Dorsey, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Antimicrobial Chemotherapy|April 25, 2009
Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustmentMarion Bouillon-Pichault, Vincent Jullien, Elie Azria, et al.
British Journal of Haematology|March 23, 2021
Deficient mitophagy pathways in sickle cell diseaseSuella Martino, Jean-Benoit Arlet, Marie-Hélène Odièvre, et al.
Pediatric Research|July 2, 2020
Pharmacokinetic study (phase I-II) of a new dobutamine formulation in preterm infants immediately after birthAdelina Pellicer, Ramón Fernández, Vincent Jullien, et al.
Infection|April 4, 2015
Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infectionsEmmanuel Curis, Vincent Pestre, Vincent Jullien, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 yearsVincent Jullien, Saïk Urien, Déborah Hirt, et al.
European Journal of Dermatology : EJD|January 22, 2014
Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combinationOlivier Join-Lambert, Florence Ribadeau-Dumas, Vincent Jullien, et al.
Malaria Journal|September 7, 2016
Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in LiberiaSabina Dahlström Otienoburu, Oumou Maïga-Ascofaré, Birgit Schramm, et al.
Antiviral Therapy|November 18, 2009
A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patientsMarion Bouillon-Pichault, Vincent Jullien, Christophe Piketty, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 26, 2021
Development of a dosing-adjustment tool for fluoroquinolones in osteoarticular infections: The Fluo-pop studyFlorian Lemaitre, Fabien Fily, Jean-Baptiste Foulquier, et al.
The Pediatric Infectious Disease Journal|March 6, 2015
The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, UgandaImke H Bartelink, Rada M Savic, Grant Dorsey, et al.
Pageof 13